After the 2023-2024 industry downturn, healthcare companies have explored more effective pathways to strengthen cash flow. A clear industry consensus has also emerged: innovation pipelines with global competitiveness and high entry barriers are now the most valuable assets.

As a long-term partner in China's innovation ecosystem, Shanghai Innovation Bank releases the China Healthcare Investments and Exits Trends Report, reviewing the logic behind the market recovery and analyzing how out-licensing of innovative pipelines and high-barrier technologies have become core growth drivers-working with all partners to explore the future direction of the healthcare industry.